Unfortunately, current therapeutic approaches for AD remain still limited to the symptomatic treatment of memory impairment by acetylcholinesterase (AChE) inhibitors, namely donepezil, rivastigmine and galantamine, and of glutamate excitotoxicity by memantine. This evidence concerns the gene ACHE and Alzheimer disease.